Categories
Tags
Auhtors: Tan X, Cai K, Li J, Yuan Z, Chen R, Xiao H, et al. PMID: 36952345 PMCID: PMC9998290 DOI: 10.1016/j.celrep.2023.112286 Abstract ER-phagy is a form of autophagy that is mediated by ER-phagy receptors and selectively degrades endoplasmic reticulum (ER). Coronaviruses have been shown to use the ER as a membrane source to establish their [...]
Categories: Cancer Care
Tags: COVID-19
Authors: Zilberman-Itskovich S, Catalogna M, Sasson E, Hadanny A, Lang E, Finci S et al. PMID: 36261911 DOI: 10.1097/01.NAJ.0000897152.36663.7a Abstract According to this study: Hyperbaric oxygen therapy can improve cognitive function, psychiatric symptoms, pain, and fatigue in patients who have post-COVID-19 condition.The beneficial effect of the therapy can be attributed to increased brain perfusion and [...]
Categories: I-RECOVER Post-Vaccine
Authors: Bek LM, Berentschot JC, Huijts S, Vlake JH, Aerts JG PMID: 36284829 PMCID: PMC9421428 DOI: 10.1183/23120541.00355-2022 Abstract Introduction: A large proportion of patients experience a wide range of sequelae after acute COVID-19, especially after severe illness. The long-term health sequelae need to be assessed. Our objective was to longitudinally assess [...]
Categories: I-RECOVER Long Covid
Tags: COVID-19, long COVID, symptoms
Authors: Arbel R, Sagy YW, Hoshen M, Battat E, Lavie G, Sergienko R et al. PMID: 36001529 PMCID: PMC9454652 DOI: 10.1056/NEJMoa2204919 Abstract Background: The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data regarding the effectiveness of [...]
Categories: I-CARE Early Covid
Tags: COVID-19, nirmatrelvir, Omicron
Auhtors: Wimalawansa SJ PMID: 35889955 PMCID: PMC9319502 DOI: 10.3390/nu14142997 Abstract Vitamin D deficiency is a global public health problem, a pandemic that commonly affects the elderly and those with comorbidities such as obesity, diabetes, hypertension, respiratory disorders, recurrent infections, immune deficiency, and malignancies, as well as ethnic minorities living in temperate countries. The same groups [...]
Categories: Cancer Care
Authors: Carpene G, Negrini D, Henry BM, Montagnana L, Lippi G PMID: 35704707 DOI: 10.1515/dx-2022-0042 Abstract Objectives: Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disorder characterized by a sustained prothrombotic state. Since homocysteine is a potential biomarker of thrombotic diseases, the aim of this article is to provide an updated overview on the possible [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19, Homocysteine
Authors: Charnley M, Islam S, Bindra G, Ratcliffe J, Zhou J, Hulett M Abstract COVID-19 is primarily known as a respiratory disease caused by SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are reported in up to 30% of cases and can persist even after the infection is [...]
Categories: I-RECOVER Post-Vaccine
Reference: A raising dawn of pentoxifylline in the management of inflammatory disorders in Covid-19.
Authors: Mostafa-Hedeab G, Al-kuraishy HM, Al-Gareeb AA, Jeandet P, Saaad HM, El-Saber Batiha G PMID: 35486310 PMCID: PMC9051499 DOI: 10.1007/s10787-022-00993-1 Abstract The existing pandemic viral infection caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as an entry-point into affected cells and [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: COVID-19, Pentoxifylline
Authors: Gupta K, Strymish J, Stack G, Chamess M DOI: https://doi.org/10.21203/rs.3.rs-1588371/v1 Abstract Initiation of NM/R treatment on Day 0 in a 71-year-old vaccinated and boosted male resulted in rapid resolution of COVID-19 symptoms followed one week later by the development of typical cold symptoms. SARS-CoV-2 viral load fluctuated in parallel with symptoms, with two distinct [...]
Categories: I-CARE Early Covid
Tags: COVID-19, nirmatrelvir, SARS-CoV-2
Authors: Brown JT, Saigal A, Karia N, Patel RK, Razvi Y, Steeden JA PMID: 35470679 PMCID: PMC9238618 DOI: 10.1161/JAHA.121.024207 Abstract Background Ongoing exercise intolerance of unclear cause following COVID-19 infection is well recognized but poorly understood. We investigated exercise capacity in patients previously hospitalized with COVID-19 with and without self-reported exercise [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19